Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.66 USD | +3.74% | +19.57% | -24.83% |
May. 13 | JPMorgan Adjusts Price Target on Prime Medicine to $15 From $16, Keeps Overweight Rating | MT |
May. 10 | Prime Medicine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Neutral | Bearish |
Resistance | 7.000 | 9.550 | 8.740 |
Spread/Res. | -4.86% | -30.26% | -23.80% |
Spread/Supp. | +24.25% | +54.88% | +50.51% |
Support | 5.360 | 4.300 | 4.425 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- PRME Stock
- Charts Prime Medicine, Inc.